NVCRNovoCure Limited

$1B

FY 2017 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$177M+113.6% YoY

Gross Profit

$121M68.6% margin

Operating Income

-$39M-22.2% margin

Net Income

-$62M-34.8% margin

EPS (Diluted)

$-0.70

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$41M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$265M

Total Liabilities

$152M

Stockholders' Equity

$114M

Cash & Equivalents

$79M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$177M	$83M	+113.6%
Gross Profit	$121M	$37M	+231.7%
Operating Income	-$39M	-$115M	+65.9%
Net Income	-$62M	-$132M	+53.2%

NVCR FY 2017 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena